Search

Your search keyword '"O'Neil, Jennifer"' showing total 463 results

Search Constraints

Start Over You searched for: Author "O'Neil, Jennifer" Remove constraint Author: "O'Neil, Jennifer"
463 results on '"O'Neil, Jennifer"'

Search Results

2. Telerehabilitation in Physical Therapist Practice: A Clinical Practice Guideline From the American Physical Therapy Association

9. Data from XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies

10. Supplementary Figure S5 from XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies

11. Supplementary Table S2 from XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies

12. Developing middle managers in the Hong Kong Public sector : a critique of leadership development from a labour process perspective

14. Do Learners Fear More than Fear Itself: The Role of Fear in Law Students Educational Experiences

15. A rapid review protocol of physiotherapy and occupational therapy telerehabilitation to inform ethical and equity concerns.

16. The emotional labour of teleworkers conducting online counselling during Covid‐19.

17. 5.13 We cannot translate evidence into clinical practice unless we know how non-pharmacological interventions following concussion are described. A systematic review

18. XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer

20. Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action

21. Author Correction: Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action

22. Caregiver and Clinician Perspectives on Missed Well-Child Visits

25. Leadership development in the Hong Kong Civil Service: Accessing social resources through guanxi networks.

26. XTX301, a tumor-activated Interleukin-12 has the potential to widen the therapeutic index of IL-12 treatment for solid tumors as evidenced by pre-clinical studies

28. 1056 XTX301, a tumor activated, half-life extended IL-12 promoted potent anti-tumor immunity and activity across multiple syngeneic tumor models

30. How completely are RCTs of non-pharmacological interventions following concussion reported? A systematic review

33. Abstract 572: Tumor-activated PD1-directed IL-2 increased antigen specific T cells in tumors and demonstrated anti-tumor activity in mice

34. Abstract 587: A half-life extended, tumor-activated IL-12 increased the infiltration of effector immune cells into the tumor microenvironment and demonstrated anti-tumor activity in syngeneic mouse models

35. Supplemental Table 1. Thirty-nine cell lines used in combination screen. from An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies

36. Supplementary Figure 1. Hierarchical clustering of response to single agent treatments. from An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies

37. Supplementary Figure 2. Experiment that was used to select drug concentrations for combination screen. from An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies

38. Supplementary Figures 1-4; Supplementary Tables 1 & 2 from High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide

39. Supplementary Data-Response Legends from An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies

40. Supplementary Figure Legends from High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide

41. Supplementary Data-Combination Response from An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies

42. Supplementary Figure Legends from An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies

43. Data from High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide

44. Supplementary Data-Single Agent Response from An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies

45. Supplementary Figures 1-5, Tables 1-2 from Inhibition of NOTCH Signaling by Gamma Secretase Inhibitor Engages the RB Pathway and Elicits Cell Cycle Exit in T-Cell Acute Lymphoblastic Leukemia Cells

46. Data from Inhibition of NOTCH Signaling by Gamma Secretase Inhibitor Engages the RB Pathway and Elicits Cell Cycle Exit in T-Cell Acute Lymphoblastic Leukemia Cells

49. A rapid review on the use of self-determination theory in physiotherapy practice: Protocol

50. 841 XTX202, a tumor-selective protein-engineered IL-2, exhibited enhanced anti-tumor activity in combination with checkpoint inhibition in mice

Catalog

Books, media, physical & digital resources